Skip to main content
Premium Trial:

Request an Annual Quote

Evonetix, Imec Collaborate on Silicon Chip Manufacturing for DNA Synthesis

NEW YORK – Evonetix announced Monday a partnership with Belgium-based nanoelectronics firm Imec to increase the scale of production of Evonetix's silicon chips for use in DNA synthesis.

Under the agreement, the firms will work together to scale up manufacturing of Evonetix's microelectromechanical systems-based chips on 8-inch silicon wafers.

"With the support of Imec, a world-renowned leader in microchip technology, we will be able to optimize our highly parallel desktop platform for commercial supply," Evonetix CTO Matthew Hayes said in a statement.

Financial and other terms of the agreement were not disclosed.

UK-based Evonetix is developing a desktop device for DNA synthesis. In 2018, it partnered with LioniX International to develop a bespoke silicon array to enable high-throughput production of gene-length DNA. Evonetix also closed a $12.3 million funding round in 2018 and launched a £1.3 million ($1.7 million) project in partnership with Durham University to develop its technology.

"We have extensive practical knowledge of chip design and technology, which we use to help develop innovative tools for the life sciences and pharma R&D," Peter Peumans, Imec VP of life science technologies, said in a statement. "Evonetix has developed an innovative approach that integrates physics and biology to enable the production of high-fidelity long DNA in a highly parallel fashion. We are eager to contribute to their success using our nanotechnology capabilities."

In March 2019, Imec announced it is working on solid-state nanopore technologies for single-molecule sensing and DNA sequencing applications.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.